![Tasuku Kitada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Tasuku Kitada is the founder of Strand Therapeutics, Inc. where he currently holds the titles of President, Secretary & Director since 2017.
He previously worked as a Senior Analyst at Candriam Belgium SA.
Aktive Positionen von Tasuku Kitada
Unternehmen | Position | Beginn |
---|---|---|
Strand Therapeutics, Inc.
![]() Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Gründer | 31.10.2017 |
Ehemalige bekannte Positionen von Tasuku Kitada
Unternehmen | Position | Ende |
---|---|---|
Candriam Belgium SA
![]() Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Analyst-Equity | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Candriam Belgium SA
![]() Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Finance |
Strand Therapeutics, Inc.
![]() Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Health Technology |